Obalon Therapeutics, Inc. logo
Obalon Therapeutics, Inc. OBLN

Obalon Therapeutics, Inc. Balance Sheet 2011-2026 | OBLN

Annual Balance Sheet Obalon Therapeutics, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

6.46 M -12.9 M -11.3 M -11.2 M -60.6 M 6.48 M -2.02 M - - -

Long Term Debt

430 K - - 7.96 M 9.88 M 9.09 M 4.88 M - - -

Total Non Current Liabilities

906 K 567 K 48 K 7.98 M 9.88 M 63.8 M 59.7 M - - -

Total Current Liabilities

5.05 M 3.98 M 17.2 M 10 M 4.59 M 5.57 M 872 K - - -

Total Liabilities

5.95 M 4.54 M 17.3 M 18 M 14.5 M 69.4 M 60.6 M - - -

Deferred Revenue

- 424 K 352 K 510 K - - - - - -

Retained Earnings

-185 M -172 M -149 M -111 M -76.6 M -56.1 M -40.6 M - - -

Total Assets

10.6 M 20.4 M 30.4 M 53.1 M 78.8 M 14.2 M 20.7 M - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of Obalon Therapeutics, Inc., providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 9.23 -1.6 % $ 261 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.46 - $ 130 M franceFrance
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 12.07 - $ 1.63 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
FONAR Corporation FONAR Corporation
FONR
$ 18.6 - $ 122 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 36.66 -0.22 % $ 5.46 K usaUSA
Globus Medical Globus Medical
GMED
$ 90.0 1.58 % $ 12.2 B usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 1.81 -4.74 % $ 1.1 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 9.25 -0.64 % $ 712 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 54.21 0.13 % $ 1.59 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 85.77 0.16 % $ 2.98 B usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 15.78 -1.0 % $ 370 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.01 1.85 % $ 17.1 M usaUSA
LENSAR LENSAR
LNSR
$ 5.82 -1.27 % $ 69.6 M usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 86.12 -0.19 % $ 111 B usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Myomo Myomo
MYO
$ 0.67 -4.9 % $ 28 M usaUSA
Align Technology Align Technology
ALGN
$ 167.26 -2.69 % $ 12.5 B usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
AxoGen AxoGen
AXGN
$ 31.33 -4.03 % $ 1.44 B usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 11.58 -1.61 % $ 459 M curacaoCuracao
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Penumbra Penumbra
PEN
$ 329.2 -0.2 % $ 12.8 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Insulet Corporation Insulet Corporation
PODD
$ 203.09 -0.2 % $ 14.3 B usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Sintx Technologies Sintx Technologies
SINT
$ 2.49 -1.58 % $ 6.91 M usaUSA
Butterfly Network Butterfly Network
BFLY
$ 4.03 -2.42 % $ 853 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 31.88 -2.3 % $ 23.8 B britainBritain
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Stryker Corporation Stryker Corporation
SYK
$ 331.18 -0.34 % $ 127 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.59 0.69 % $ 36.7 M usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 24.49 -0.33 % $ 560 M usaUSA
TELA Bio TELA Bio
TELA
$ 0.62 -2.08 % $ 29.1 M usaUSA
TransMedics Group TransMedics Group
TMDX
$ 104.84 0.04 % $ 3.56 B usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 19.55 1.98 % $ 1.33 B usaUSA
Delcath Systems Delcath Systems
DCTH
$ 9.61 -0.98 % $ 344 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 61.27 -2.11 % $ 90.7 B usaUSA